The short answer is… no.
The main difference is the legal framework that the plants were grown and processed under. Some states have very clear lines and others are more blurred.
When it comes to purchasing CBDa from the recreational/medical market and access to CBDa from the hemp market, the contrast is stark.
With the passing of the 2018 Farm Bill (USDA), all 50 states have been given an open door by the federal government to set up licensing programs for cultivation, processing and interstate commerce of cannabis plants containing less than 0.3% total THC (legally designated as “hemp”).
Many CBDa/CBD consumers have found it exceedingly difficult to find high quality products that are consistently available through their recreational and/or medical cannabis dispensaries. With taxes high and supply low, cost alone can be a huge barrier in the recreational and medical markets, not to mention many dispensaries only stock a couple token CBD products that may sit on the shelf for months and months.
With these issues being prevalent in the recreational and medical dispensary markets, many have opted to get CBDa and CBD from hemp. This has its own set of challenges as much of CBDa/CBD from hemp can be of low quality and is often not tested for the bad stuff (mold, heavy metals, pesticides) and good stuff (cannabinoids, terpenes). However, when the consumer does find a company making high quality products that work for them, there are huge advantages. Consumers can order from their own home and not have to deal with braving a dispensary. Additionally, access to cultivar specific products (like from Circle Labs) is not available at the vast majority of dispensaries. This translates to a consistent product with predictable results, available year round, on demand without leaving home.